Michael F. Nash
Keine laufenden Positionen mehr
Profil
Michael F.
Nash is the founder of iScience Interventional Corp.
which was founded in 1999.
He held the titles of President & Chief Executive Officer from 2010 to 2013.
Mr. Nash's former jobs include being a Principal at General Surgical Innovations, Inc., Orthopedic Technology, Inc., Ioptex Research, Inc., and American Hospital Supply Corp.
He also served as the Executive Vice President-Sales & Marketing at Oculex Pharmaceuticals, Inc. Mr. Nash's education includes an MBA from Pepperdine University and an undergraduate degree from the University of Michigan.
Ehemalige bekannte Positionen von Michael F. Nash
| Unternehmen | Position | Ende |
|---|---|---|
| American Hospital Supply Corp. | Corporate Officer/Principal | - |
Ioptex Research, Inc.
 Ioptex Research, Inc. Electronic ComponentsElectronic Technology Part of AbbVie, Inc., Ioptex Research, Inc. is a company that manufactures ophthalmic lenses. The company is based in Irwindale, CA. Ioptex Research was acquired by Allergan, Inc., part of AbbVie, Inc. from June 15, 2015 on September 08, 1994 for $16 million. | Corporate Officer/Principal | - |
| Orthopedic Technology, Inc. | Corporate Officer/Principal | - |
Oculex Pharmaceuticals, Inc.
 Oculex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oculex Pharmaceuticals, Inc. manufactures and develops drugs. The company focuses on developing and manufacturing novel drug delivery systems that resolve the problems associated with treatment of inflammation following cataract surgery and diseases of the eye. It is located in Sunnyvale, CA. | Vertrieb & Marketing | - |
| General Surgical Innovations, Inc. | Corporate Officer/Principal | - |
Ausbildung von Michael F. Nash
| Pepperdine University | Masters Business Admin |
| University of Michigan | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
| General Surgical Innovations, Inc. | Health Technology |
iScience Interventional Corp.
 iScience Interventional Corp. Medical/Nursing ServicesHealth Services iScience Interventional Corp. discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific ocular therapies. It encompasses microcatheter-based therapies designed to access anatomical structures within the eye to aspirate ocular fluids or deliver sterile ophthalmic solutions to the eye. The firm addresses the previously unmet need for treatment of sight-threatening diseases with the innovative, minimally invasive iCath™ procedures. The company was founded by Michael F. Nash and Stan Conston in 1999 and is headquartered in Menlo Park, CA. | Health Services |
| Orthopedic Technology, Inc. | Health Technology |
Ioptex Research, Inc.
Ioptex Research, Inc. Electronic ComponentsElectronic Technology Part of AbbVie, Inc., Ioptex Research, Inc. is a company that manufactures ophthalmic lenses. The company is based in Irwindale, CA. Ioptex Research was acquired by Allergan, Inc., part of AbbVie, Inc. from June 15, 2015 on September 08, 1994 for $16 million. | Electronic Technology |
| American Hospital Supply Corp. | Health Technology |
Oculex Pharmaceuticals, Inc.
Oculex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oculex Pharmaceuticals, Inc. manufactures and develops drugs. The company focuses on developing and manufacturing novel drug delivery systems that resolve the problems associated with treatment of inflammation following cataract surgery and diseases of the eye. It is located in Sunnyvale, CA. | Health Technology |
